BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 34506231)

  • 21. Efficacy-shaping nanomedicine by loading Calcium Peroxide into Tumor Microenvironment-responsive Nanoparticles for the Antitumor Therapy of Prostate Cancer.
    Wu D; Zhu ZQ; Tang HX; Shi ZE; Kang J; Liu Q; Qi J
    Theranostics; 2020; 10(21):9808-9829. PubMed ID: 32863961
    [No Abstract]   [Full Text] [Related]  

  • 22. Cancer cell membrane-cloaked mesoporous silica nanoparticles with a pH-sensitive gatekeeper for cancer treatment.
    Liu CM; Chen GB; Chen HH; Zhang JB; Li HZ; Sheng MX; Weng WB; Guo SM
    Colloids Surf B Biointerfaces; 2019 Mar; 175():477-486. PubMed ID: 30572156
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual targeting mesoporous silica nanoparticles for inhibiting tumour cell invasion and metastasis.
    Li W; Guo Z; Zheng K; Ma K; Cui C; Wang L; Yuan Y; Tang Y
    Int J Pharm; 2017 Dec; 534(1-2):71-80. PubMed ID: 28958879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In Vitro Evaluation of pH Responsive Doxazosin Loaded Mesoporous Silica Nanoparticles: A Smart Approach in Drug Delivery.
    Guha A; Biswas N; Bhattacharjee K; Das P; Kuotsu K
    Curr Drug Deliv; 2016; 13(4):574-81. PubMed ID: 26201344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amino-functionalized mesoporous silica nanoparticles as efficient carriers for anticancer drug delivery.
    He Y; Luo L; Liang S; Long M; Xu H
    J Biomater Appl; 2017 Oct; 32(4):524-532. PubMed ID: 28776488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol loaded oxidized mesoporous carbon nanoparticles: A promising tool to treat triple negative breast cancer.
    Fan C; Kong F; Shetti D; Zhang B; Yang Y; Wei K
    Biochem Biophys Res Commun; 2019 Nov; 519(2):378-384. PubMed ID: 31519327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced chemotherapy of cancer using pH-sensitive mesoporous silica nanoparticles to antagonize P-glycoprotein-mediated drug resistance.
    Huang IP; Sun SP; Cheng SH; Lee CH; Wu CY; Yang CS; Lo LW; Lai YK
    Mol Cancer Ther; 2011 May; 10(5):761-9. PubMed ID: 21411714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrol.
    Summerlin N; Qu Z; Pujara N; Sheng Y; Jambhrunkar S; McGuckin M; Popat A
    Colloids Surf B Biointerfaces; 2016 Aug; 144():1-7. PubMed ID: 27060664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biocompatible mesoporous silica-coated superparamagnetic manganese ferrite nanoparticles for targeted drug delivery and MR imaging applications.
    Sahoo B; Devi KS; Dutta S; Maiti TK; Pramanik P; Dhara D
    J Colloid Interface Sci; 2014 Oct; 431():31-41. PubMed ID: 24980623
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zwitterionic mesoporous nanoparticles with a bioresponsive gatekeeper for cancer therapy.
    Khatoon S; Han HS; Lee M; Lee H; Jung DW; Thambi T; Ikram M; Kang YM; Yi GR; Park JH
    Acta Biomater; 2016 Aug; 40():282-292. PubMed ID: 27063494
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smart MSN-Drug-Delivery System for Tumor Cell Targeting and Tumor Microenvironment Release.
    Dong JH; Ma Y; Li R; Zhang WT; Zhang MQ; Meng FN; Ding K; Jiang HT; Gong YK
    ACS Appl Mater Interfaces; 2021 Sep; 13(36):42522-42532. PubMed ID: 34463488
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mesoporous silica nanoparticle based enzyme responsive system for colon specific drug delivery through guar gum capping.
    Kumar B; Kulanthaivel S; Mondal A; Mishra S; Banerjee B; Bhaumik A; Banerjee I; Giri S
    Colloids Surf B Biointerfaces; 2017 Feb; 150():352-361. PubMed ID: 27847225
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Facile synthesis of pH sensitive polymer-coated mesoporous silica nanoparticles and their application in drug delivery.
    Tang H; Guo J; Sun Y; Chang B; Ren Q; Yang W
    Int J Pharm; 2011 Dec; 421(2):388-96. PubMed ID: 22001840
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Resveratrol-laden mesoporous silica nanoparticles regulate the autophagy and apoptosis via ROS-mediated p38-MAPK/HIF-1a /p53 signaling in hypertrophic scar fibroblasts.
    Zuo J; Ma S
    Heliyon; 2024 Feb; 10(4):e24985. PubMed ID: 38370262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: In vitro/in vivo evaluation and binding properties investigation.
    Zhao Y; Cai C; Liu M; Zhao Y; Wu Y; Fan Z; Ding Z; Zhang H; Wang Z; Han J
    Int J Biol Macromol; 2020 Jun; 153():873-882. PubMed ID: 32169451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gold nanoparticle-gated mesoporous silica as redox-triggered drug delivery for chemo-photothermal synergistic therapy.
    Yang Y; Lin Y; Di D; Zhang X; Wang D; Zhao Q; Wang S
    J Colloid Interface Sci; 2017 Dec; 508():323-331. PubMed ID: 28843922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermo- and pH-responsive, Lipid-coated, Mesoporous Silica Nanoparticle-based Dual Drug Delivery System To Improve the Antitumor Effect of Hydrophobic Drugs.
    Feng Y; Li NX; Yin HL; Chen TY; Yang Q; Wu M
    Mol Pharm; 2019 Jan; 16(1):422-436. PubMed ID: 30525641
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells.
    Niemelä E; Desai D; Nkizinkiko Y; Eriksson JE; Rosenholm JM
    Eur J Pharm Biopharm; 2015 Oct; 96():11-21. PubMed ID: 26184689
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mesoporous silica as topical nanocarriers for quercetin: characterization and in vitro studies.
    Sapino S; Ugazio E; Gastaldi L; Miletto I; Berlier G; Zonari D; Oliaro-Bosso S
    Eur J Pharm Biopharm; 2015 Jan; 89():116-25. PubMed ID: 25478737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delivery of chemically glycosylated cytochrome c immobilized in mesoporous silica nanoparticles induces apoptosis in HeLa cancer cells.
    Méndez J; Morales Cruz M; Delgado Y; Figueroa CM; Orellano EA; Morales M; Monteagudo A; Griebenow K
    Mol Pharm; 2014 Jan; 11(1):102-11. PubMed ID: 24294910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.